E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus–Positive Oropharyngeal Squamous Cell Carcinoma
暂无分享,去创建一个
Jeremy MG Taylor | L. Rozek | K. Malloy | A. Eisbruch | C. Bradford | G. Wolf | D. Chepeha | J. Mchugh | M. Prince | J. Moyer | F. Worden | K. Sun | T. Jones | E. Bellile | P. Swiecicki | M. Spector | Jeremy M. G. Taylor | A. Sacco | A. Birkeland | Tamara R. Jones | Assutina G. Sacco | W. Brown
[1] A. Eisbruch,et al. Matted nodes as a predictor of distant metastasis in advanced‐stage III/IV oropharyngeal squamous cell carcinoma , 2016, Head & neck.
[2] Daria A. Gaykalova,et al. Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer , 2015, Cancer Prevention Research.
[3] C. Chung,et al. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma. , 2015, JAMA oncology.
[4] Carole Fakhry,et al. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Qingyi Wei,et al. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status. , 2015, Oral oncology.
[6] K. Anderson,et al. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx , 2015, Clinical Cancer Research.
[7] David J Sher,et al. Human papillomavirus and head and neck cancer. , 2015, International journal of radiation oncology, biology, physics.
[8] J. Califano,et al. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer. , 2014, JAMA otolaryngology-- head & neck surgery.
[9] E. Sturgis,et al. Epidemiology of HPV-associated oropharyngeal cancer. , 2014, Oral oncology.
[10] A. Eisbruch,et al. High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods. , 2013, JAMA otolaryngology-- head & neck surgery.
[11] Wei Xu,et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] A. Eisbruch,et al. Matted nodes: Poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status , 2012, Head & neck.
[13] S. McBride,et al. Active tobacco smoking and distant metastasis in patients with oropharyngeal cancer. , 2012, International journal of radiation oncology, biology, physics.
[14] Gypsyamber D'Souza,et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. , 2010, The Lancet. Oncology.
[15] K. Ang,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.
[16] F. Feng,et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Jens Overgaard,et al. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] C. Tsien,et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] W. Westra,et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. , 2008, Journal of the National Cancer Institute.
[20] E. Sturgis,et al. Trends in head and neck cancer incidence in relation to smoking prevalence , 2007, Cancer.
[21] F. Feng,et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. , 2007, International journal of radiation oncology, biology, physics.
[22] H. Wanebo,et al. Changing patterns of failure of head and neck cancer. , 2002, Archives of otolaryngology--head & neck surgery.
[23] M. Pawlita,et al. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. , 2001, Journal of immunological methods.